Course in Progress?

If you need to access a course in progress, go directly to our education site.

Looking for something new, search our course and resource listing.

Featured Events

April 7, 2026
Evidence-based Treatments for Stimulant Use Disorder
April 8, 2026
PCSS-MOUD Exchange 4 – Session Roadmap, Session 2 – Prepare
April 8, 2026
Breaking the Cycle: Preventing Substance Use Disorders in Children and Youth Impacted by Family and Community Addiction
April 10, 2026
Office Hours with Christa Cuellar, FNP-C
April 15, 2026
PCSS-MOUD Exchange 4 – Session Roadmap, Session 3 – Implement/Sustain
April 22, 2026
PCSS-MOUD Exchange 4 – Session Roadmap, Session 4 – Implement/Sustain
May 6, 2026
PCSS MOUD Online Case-based Learning Collaboratives Session 2: Strategies to Effectively Manage Complicated Opioid Withdrawal in the Emergency Department or Hospital Setting
June 3, 2026
PCSS-MOUD Exchange 4 – Session Roadmap, Session 1 – Explore
June 10, 2026
PCSS-MOUD Exchange 4 – Session Roadmap, Session 2 – Prepare
June 17, 2026
PCSS-MOUD Exchange 4 – Session Roadmap, Session 3 – Implement/Sustain

Latest News

SAMHSA
April 3, 2026

Join SAMHSA to Discuss the Report on Community-Initiated Care in Behavioral Healths: Exploring Funding Mechanisms for Substance Use Disorders

SAMHSA’s Center for Financing Reform and Innovation (CFRI) is releasing a report and hosting a webinar Community-Initiated Care in Behavioral Health: Exploring Funding Mechanisms for Substance Use Disorders on Tuesday, April 21, 2-3 p.m. ET.
Addiction Policy Forum
March 26, 2026

Extended-Release Buprenorphine Linked to Higher Opioid Abstinence in Pregnancy Than Daily Treatment

A randomized clinical trial published in JAMA Internal Medicine found that weekly extended-release buprenorphine during pregnancy was associated with higher rates of abstinence from illicit opioids than daily sublingual buprenorphine among pregnant women with opioid use disorder.
Close up Stethoscope. Doctor working in hospital
March 26, 2026

Extended-Release Buprenorphine Utilization in Justice Settings: Insights from Two JCOIN Studies

Friends Research Hub conducted two recent JCOIN 1.0 studies that offer complementary perspectives on how extended-release buprenorphine (XR-B) can be initiated and sustained across incarceration and reentry.